Efficacy of remimazolam in preventing postoperative nausea and vomiting: a systematic review and meta-analysis

Abstract This meta-analysis aimed to evaluate the efficacy of remimazolam, a newly introduced anesthetic, in preventing postoperative nausea and vomiting (PONV) compared to other anesthetics. A systematic search of studies published up to January 2024 in PubMed, Cochrane Library, and Embase was cond...

Full description

Saved in:
Bibliographic Details
Main Authors: Hyun-Su Ri, Soeun Jeon, Jinseok Yeo, Hoon Jung, Christine Kang, Hyojun Choo
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-14976-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849237727595200512
author Hyun-Su Ri
Soeun Jeon
Jinseok Yeo
Hoon Jung
Christine Kang
Hyojun Choo
author_facet Hyun-Su Ri
Soeun Jeon
Jinseok Yeo
Hoon Jung
Christine Kang
Hyojun Choo
author_sort Hyun-Su Ri
collection DOAJ
description Abstract This meta-analysis aimed to evaluate the efficacy of remimazolam, a newly introduced anesthetic, in preventing postoperative nausea and vomiting (PONV) compared to other anesthetics. A systematic search of studies published up to January 2024 in PubMed, Cochrane Library, and Embase was conducted to identify randomized controlled trials (RCTs) comparing remimazolam with other anesthetics in terms of PONV. Following data synthesis, outcomes were reported as the relative risk (RR) with 95% confidence interval (95% CI). Subgroup analyses were performed according to the type of comparator anesthetic. A total of 50 RCTs involving 9,193 participants were included. The results showed no significant difference in PONV incidence between remimazolam and other anesthetic agents (RR: 0.96, 95% CI: 0.80–1.13, P = 0.607). However, subgroup analysis demonstrated that a lower incidence of overall PONV was associated with remimazolam compared with inhalation anesthetics (n = 363; RR: 0.50; 95% CI: 0.34–0.73; P < 0.001). Conversely, a higher incidence of postoperative vomiting was associated with remimazolam compared with propofol (n = 3,860; RR: 1.41; 95% CI: 1.05–1.90; P = 0.024). Overall, there was no significant difference between remimazolam and other anesthetic agents in preventing PONV. However, subgroup analysis revealed that remimazolam was more effective than inhalation anesthetics in mitigating PONV, and it was inferior to propofol in preventing postoperative vomiting.
format Article
id doaj-art-e6b44014cdcb4f67bb3b6942cfd8e663
institution Kabale University
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e6b44014cdcb4f67bb3b6942cfd8e6632025-08-20T04:01:52ZengNature PortfolioScientific Reports2045-23222025-08-0115111610.1038/s41598-025-14976-zEfficacy of remimazolam in preventing postoperative nausea and vomiting: a systematic review and meta-analysisHyun-Su Ri0Soeun Jeon1Jinseok Yeo2Hoon Jung3Christine Kang4Hyojun Choo5Department of Anesthesia and Pain Medicine, School of Medicine, Kyungpook National UniversityDepartment of Anesthesia and Pain Medicine, School of Medicine, Kyungpook National University Chilgok Hospital, Kyungpook National UniversityDepartment of Anesthesia and Pain Medicine, School of Medicine, Kyungpook National UniversityDepartment of Anesthesia and Pain Medicine, School of Medicine, Kyungpook National UniversityDepartment of Critical Care Medicine, Seoul National University HospitalDepartment of Anesthesia and Pain Medicine, School of Medicine, Kyungpook National University Chilgok Hospital, Kyungpook National UniversityAbstract This meta-analysis aimed to evaluate the efficacy of remimazolam, a newly introduced anesthetic, in preventing postoperative nausea and vomiting (PONV) compared to other anesthetics. A systematic search of studies published up to January 2024 in PubMed, Cochrane Library, and Embase was conducted to identify randomized controlled trials (RCTs) comparing remimazolam with other anesthetics in terms of PONV. Following data synthesis, outcomes were reported as the relative risk (RR) with 95% confidence interval (95% CI). Subgroup analyses were performed according to the type of comparator anesthetic. A total of 50 RCTs involving 9,193 participants were included. The results showed no significant difference in PONV incidence between remimazolam and other anesthetic agents (RR: 0.96, 95% CI: 0.80–1.13, P = 0.607). However, subgroup analysis demonstrated that a lower incidence of overall PONV was associated with remimazolam compared with inhalation anesthetics (n = 363; RR: 0.50; 95% CI: 0.34–0.73; P < 0.001). Conversely, a higher incidence of postoperative vomiting was associated with remimazolam compared with propofol (n = 3,860; RR: 1.41; 95% CI: 1.05–1.90; P = 0.024). Overall, there was no significant difference between remimazolam and other anesthetic agents in preventing PONV. However, subgroup analysis revealed that remimazolam was more effective than inhalation anesthetics in mitigating PONV, and it was inferior to propofol in preventing postoperative vomiting.https://doi.org/10.1038/s41598-025-14976-zRemimazolamPostoperative nausea and vomitingNauseaVomitingAnestheticsPostoperative emesis
spellingShingle Hyun-Su Ri
Soeun Jeon
Jinseok Yeo
Hoon Jung
Christine Kang
Hyojun Choo
Efficacy of remimazolam in preventing postoperative nausea and vomiting: a systematic review and meta-analysis
Scientific Reports
Remimazolam
Postoperative nausea and vomiting
Nausea
Vomiting
Anesthetics
Postoperative emesis
title Efficacy of remimazolam in preventing postoperative nausea and vomiting: a systematic review and meta-analysis
title_full Efficacy of remimazolam in preventing postoperative nausea and vomiting: a systematic review and meta-analysis
title_fullStr Efficacy of remimazolam in preventing postoperative nausea and vomiting: a systematic review and meta-analysis
title_full_unstemmed Efficacy of remimazolam in preventing postoperative nausea and vomiting: a systematic review and meta-analysis
title_short Efficacy of remimazolam in preventing postoperative nausea and vomiting: a systematic review and meta-analysis
title_sort efficacy of remimazolam in preventing postoperative nausea and vomiting a systematic review and meta analysis
topic Remimazolam
Postoperative nausea and vomiting
Nausea
Vomiting
Anesthetics
Postoperative emesis
url https://doi.org/10.1038/s41598-025-14976-z
work_keys_str_mv AT hyunsuri efficacyofremimazolaminpreventingpostoperativenauseaandvomitingasystematicreviewandmetaanalysis
AT soeunjeon efficacyofremimazolaminpreventingpostoperativenauseaandvomitingasystematicreviewandmetaanalysis
AT jinseokyeo efficacyofremimazolaminpreventingpostoperativenauseaandvomitingasystematicreviewandmetaanalysis
AT hoonjung efficacyofremimazolaminpreventingpostoperativenauseaandvomitingasystematicreviewandmetaanalysis
AT christinekang efficacyofremimazolaminpreventingpostoperativenauseaandvomitingasystematicreviewandmetaanalysis
AT hyojunchoo efficacyofremimazolaminpreventingpostoperativenauseaandvomitingasystematicreviewandmetaanalysis